
Coronavirus Vaccine - Global Market Outlook (2018-2027)
According to Stratistics MRC, the Global Coronavirus Vaccine Market is accounted for $18.69 million in 2018 and is expected to reach $900.14 million by 2027 growing at a CAGR of 53.8% during the forecast period. The increasing prevalence of virus infected people across the world is anticipated to drive the growth of the market. However, factors such as high cost involved in research and development of therapeutic vaccines and drugs, and time required for each stage of clinical trials are hampering the market growth.
Corona viruses are a group of viruses which cause diseases or infections in mammals as well as birds. Coronaviruses belong to the Coronaviridae or Torovirinae subfamily. Symptoms caused by these viruses include common cold to serious infections, pneumonia, strict respiratory complications, even kidney failure, and death. These symptoms are common among persons with a weak immune system, individuals with cardiopulmonary disease, infants, and elderly people.
Based on the vaccine type, the DNA-based vaccine segment is going to have a lucrative growth during the forecast period the technological advancements in the field of pharmaceutical industry have resulted in development of various effective type of vaccines such as DNA-based nucleic acid vaccines. The use of these vaccines on human body leads to development of anti-gen. Thus, the effectiveness of the vaccine against the virus is enhanced significantly.
By geography, Europe is likely to have a huge demand due to diverse coronavirus outbreaks in the current past and presence of major players in countries in the region. As well, rising investments in R&D activities, along with strong support from the government is driving the growth of the target market in this region.
Some of the key players profiled in the Coronavirus Vaccine Market include Inovio Pharmaceuticals, Inc., Moderna, Inc., Protein Potential, LLC, Novavax, Inc., Synairgen PLC, AlphaVax, Inc., NanoViricides, Inc., Zydus Cadila, Bravovax, GeoVax, Altimmune, Janssen Pharmaceutical Companies, CanSino Biologics, Vaxart and Vaxil Bio Ltd.
Infection Types Covered:
• HCoV-229E
• HCoV-OC43
• HKU1-CoV
• MERS-CoV
• New Haven CoV
• SARS-CoV
Vaccine Types Covered:
• S-Protein Based Coronavirus Vaccine
• Live Attenuated Coronavirus Vaccine
• Inactivated Coronavirus Vaccine
• mRNA Vaccine
• DNA-Based Vaccine
Product Types Covered:
• Monovalent Vaccine
• Multivariant Vaccine
Route of Administrations Covered:
• Subcutaneous
• Oral
• Intramuscular
Patient Types Covered:
• Pediatric
• Adult
End Users Covered:
• Clinics
• Hospitals
• Research Institutes
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Select License Type
WHY CHOOSE US ?

Assured Quality
Best in class reports with high standard of research integrity

24X7 Research Support
Continuous support to ensure the best customer experience.

Free Customization
Adding more values to your product of interest.

Safe & Secure Access
Providing a secured environment for all online transactions.

Trusted by 600+ Brands
Serving the most reputed brands across the world.